Trial intelligence / Profile preview

Inflexal V vs Agrippal in Healthy Young Children

NCT01310400Phase 3Completed

Sponsor
Crucell
Start
Oct 2009
Primary completion
Jan 2010
Modality
Nanoparticles, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Inflexal V in influenza, sponsored by Crucell. Started Oct 2009; status: completed.

02

Drugs

Inflexal V
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01310400.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01310400.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call